Stay updated on UCART19 Dose Escalation Study in B-cell ALL Clinical Trial

Sign up to get notified when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.8%
    Check dated 2025-05-08T13:36:30.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:10:40.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page has been updated to include new information about B-cell Acute Lymphoblastic Leukemia and the EudraCT number, while significant details about the study's design and inclusion/exclusion criteria have been removed.
    Difference
    14%
    Check dated 2025-04-23T23:12:19.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.9%
    Check dated 2025-04-09T14:50:17.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has removed references to Acute Graft Versus Host Disease and added information about Acute Lymphoblastic Leukemia.
    Difference
    0.5%
    Check dated 2025-04-02T00:21:55.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-03-18T14:18:42.000Z thumbnail image

Stay in the know with updates to UCART19 Dose Escalation Study in B-cell ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.